Rockstroh J - Search Results

1

Host and disease factors are associated with cognitive function in European HIV-infected adults prior to initiation of antiretroviral therapy.

Winston A, Stöhr W, Antinori A, Arenas-Pinto A, Llibre JM, Amieva H, Cabié A, Williams I, Di Perri G, Tellez MJ, Rockstroh J, Babiker A, Pozniak A, Raffi F, Richert L; NEAT 001/Agence Nationale de Recherche sur le SIDA (ANRS) 143 Study Group. Winston A, et al. Among authors: rockstroh j. HIV Med. 2016 Jun;17(6):471-8. doi: 10.1111/hiv.12344. Epub 2015 Nov 26. HIV Med. 2016. PMID: 26611175 Free article.

2

Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV-HCV International Panel.

Soriano V, Sulkowski M, Bergin C, Hatzakis A, Cacoub P, Katlama C, Cargnel A, Mauss S, Dieterich D, Moreno S, Ferrari C, Poynard T, Rockstroh J. Soriano V, et al. Among authors: rockstroh j. AIDS. 2002 Apr 12;16(6):813-28. doi: 10.1097/00002030-200204120-00001. AIDS. 2002. PMID: 11919483 Review. No abstract available.

3

Incidence and predictors of severe liver fibrosis in human immunodeficiency virus-infected patients with chronic hepatitis C: a European collaborative study.

Martín-Carbonero L, Benhamou Y, Puoti M, Berenguer J, Mallolas J, Quereda C, Arizcorreta A, Gonzalez A, Rockstroh J, Asensi V, Miralles P, Laguno M, Moreno L, Girón JA, Vogel M, García-Samaniego J, Nuñez M, Romero M, Moreno S, de la Cruz JJ, Soriano V. Martín-Carbonero L, et al. Among authors: rockstroh j. Clin Infect Dis. 2004 Jan 1;38(1):128-33. doi: 10.1086/380130. Epub 2003 Dec 8. Clin Infect Dis. 2004. PMID: 14679458

4

Clinical management of treatment-experienced, HIV-infected patients with the fusion inhibitor enfuvirtide: consensus recommendations.

Clotet B, Raffi F, Cooper D, Delfraissy JF, Lazzarin A, Moyle G, Rockstroh J, Soriano V, Schapiro J. Clotet B, et al. Among authors: rockstroh j. AIDS. 2004 May 21;18(8):1137-46. doi: 10.1097/00002030-200405210-00007. AIDS. 2004. PMID: 15166529 Review.

5

Progressive multifocal leukencephalopathy in patients on highly active antiretroviral therapy: survival and risk factors of death.

Wyen C, Hoffmann C, Schmeisser N, Wöhrmann A, Qurishi N, Rockstroh J, Esser S, Rieke A, Ross B, Lorenzen T, Schmitz K, Stenzel W, Salzberger B, Fätkenheuer G. Wyen C, et al. Among authors: rockstroh j. J Acquir Immune Defic Syndr. 2004 Oct 1;37(2):1263-8. doi: 10.1097/01.qai.0000136093.47316.f3. J Acquir Immune Defic Syndr. 2004. PMID: 15385733

6

Is there evidence for an increase in the death rate from liver-related disease in patients with HIV?

Mocroft A, Soriano V, Rockstroh J, Reiss P, Kirk O, de Wit S, Gatell J, Clotet B, Phillips AN, Lundgren JD; EuroSIDA Study Group. Mocroft A, et al. Among authors: rockstroh j. AIDS. 2005 Dec 2;19(18):2117-25. doi: 10.1097/01.aids.0000194799.43799.ea. AIDS. 2005. PMID: 16284461

7

Are specific antiretrovirals associated with an increased risk of discontinuation due to toxicities or patient/physician choice in patients with hepatitis C virus coinfection?

Mocroft A, Rockstroh J, Soriano V, Ledergerber B, Kirk O, Vinogradova E, Reiss P, Katlama C, Phillips AN, Lundgren JD; EuroSIDA Study Group. Mocroft A, et al. Among authors: rockstroh j. Antivir Ther. 2005;10(7):779-90. Antivir Ther. 2005. PMID: 16312175 Clinical Trial.

8

Limited but increasing use of treatment for hepatitis C across Europe in patients coinfected with HIV and hepatitis C.

Mocroft A, Rockstroh J, Soriano V, Kirk O, Viard JP, Caplinskas S, Gasiorowski J, Chiesi A, Phillips AN, Lundgren JD; EuroSIDA Study Group. Mocroft A, et al. Among authors: rockstroh j. Scand J Infect Dis. 2006;38(11-12):1092-7. doi: 10.1080/00365540600786515. Scand J Infect Dis. 2006. PMID: 17148084

9

Efficacy and safety of TMC114/ritonavir in treatment-experienced HIV patients: 24-week results of POWER 1.

Katlama C, Esposito R, Gatell JM, Goffard JC, Grinsztejn B, Pozniak A, Rockstroh J, Stoehr A, Vetter N, Yeni P, Parys W, Vangeneugden T; POWER 1 study group. Katlama C, et al. Among authors: rockstroh j. AIDS. 2007 Feb 19;21(4):395-402. doi: 10.1097/QAD.0b013e328013d9d7. AIDS. 2007. PMID: 17301557 Clinical Trial.

10

Risk of discontinuation of nevirapine due to toxicities in antiretroviral-naive and -experienced HIV-infected patients with high and low CD4+ T-cell counts.

Mocroft A, Staszewski S, Weber R, Gatell J, Rockstroh J, Gasiorowski J, Panos G, Monforte Ad, Rakhmanova A, Phillips AN, Lundgren JD; EuroSIDA study group. Mocroft A, et al. Among authors: rockstroh j. Antivir Ther. 2007;12(3):325-33. Antivir Ther. 2007. PMID: 17591022 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

831 results

Search Page